Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals
Resource utilization and in-hospital costs for patients undergoing SRT are lower in high procedural volume hospitals than low procedural volume hospitals. SRT procedure volume remains low even in hospitals with the highest relative procedural volumes, highlighting a need for globally accessible therapies that improve outcomes.
Authors
- Shanthi Krishnaswami (ORCID: https://orcid.org/0000-0003-4162-8024)
- Zhun Cao (ORCID: https://orcid.org/0000-0002-7904-2523)
- Ervant J. Maksabedian Hernandez (ORCID: https://orcid.org/0000-0003-1945-3061)
- Craig Lipkin (ORCID: https://orcid.org/0000-0001-8829-6747)
- Annemijn H. Jonkman (ORCID: https://orcid.org/0000-0001-8778-5135)
- Andrew Wang (ORCID: https://orcid.org/0000-0001-8729-0933)
- Manu Tyagi
- Anandkumar Dubey
- Nisha Singh
Institutions
- Bristol-Myers Squibb (Germany) (DE)
- Bristol-Myers Squibb (United States) (US)
- Duke University Hospital (US)
- Premier Research Group (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1080/13696998.2025.2468127
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78